老虎证券

美股详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务

Auris Medical Holding AG

3.05
0.0000
成交量：- -
成交额：- -
市值：3,918.79万
市盈率：-1.98
高：3.05
开：3.05
低：3.05
收：3.05
52周最高：6.60
52周最低：0.7255
股本：1,286.96万
流通股本：1,219.92万
量比：- -
换手率：- -
股息：- -
股息率：- -
每股收益(TTM):-1.5411
每股收益(LYR):-1.5411
净资产收益率：-71.91%
总资产收益率：-21.99%
市净率：1.81
市盈率(LYR):-1.98

数据加载中...

总览公司新闻资讯公告
2021/05/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/31

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/31

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/21

SEC问询函

CORRESP [Cover] - Correspondence
2020/10/06

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/17

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/19

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/08

SEC问询函

CORRESP [Cover] - Correspondence
2020/04/29

招股说明书

Registration statement for certain foreign private issuers
2020/04/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
更多